| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2024 | OM Outset Medical, Inc. | Williamson Steven S.83 | Chief Commercial Officer | Sell | 7,055 | $5.49 | $38,731.95 | -6.2% | -53.0% | -79.6% | |
| Jan 8, 2024 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 7,344 | $5.49 | $40,318.56 | -13.1% | -53.0% | -79.6% | |
| Jan 8, 2024 | OM Outset Medical, Inc. | Ahmed Nabeel84 | Chief Financial Officer | Sell | 10,709 | $5.49 | $58,792.41 | -12.2% | -53.0% | -79.6% | |
| Jan 8, 2024 | STAA Staar Surgical Co | Broadwood Partners, L.P.60 | 10% Owner | Buy | 4,042 | $27.11 | $109,570.13 | - | +55.9% | -24.8% | |
| Jan 8, 2024 | OM Outset Medical, Inc. | Porter Stacey L.89 | Chief People Officer | Sell | 4,766 | $5.49 | $26,165.34 | -7.5% | -53.0% | -79.6% | |
| Jan 8, 2024 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 14,188 | $5.49 | $77,892.12 | -3.5% | -53.0% | -79.6% | |
| Jan 8, 2024 | RXST Rxsight, Inc. | Corley Jesse Anderson | Director | Sell | 2,000 | $45.03 | $90,058.60 | -14.7% | +24.4% | -21.4% | |
| Jan 8, 2024 | RXST Rxsight, Inc. | Maniar Shweta62 | Director | Sell | 6,418 | $45.00 | $288,810.00 | -25.7% | +24.4% | -21.4% | |
| Jan 8, 2024 | RXST Rxsight, Inc. | Weinberg Eric57 | Chief Commercial Officer | Sell | 10,000 | $42.00 | $420,000.00 | -2.9% | +24.4% | -21.4% | |
| Jan 8, 2024 | OM Outset Medical, Inc. | Racine Jean-Olivier85 | Chief Technology Officer | Sell | 3,905 | $5.49 | $21,438.45 | -5.0% | -53.0% | -79.6% | |
| Jan 8, 2024 | RXST Rxsight, Inc. | Kurtz Ronald M Md55 | President &CEO | Sell | 62,500 | $44.25 | $2,765,631.25 | -3.7% | +24.4% | -21.4% | |
| Jan 8, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | Chief Operating Officer | Sell | 15,000 | $43.33 | $650,000.00 | -13.7% | +24.4% | -21.4% | |
| Jan 5, 2024 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Director | Sell | 29,350 | $72.98 | $2,142,089.00 | -45.0% | +25.2% | +1.5% | |
| Jan 5, 2024 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 35,612 | $1.02 | $36,324.24 | -3.5% | -1.2% | +302.0% | |
| Jan 5, 2024 | BFLY Butterfly Network, Inc. | Getz Heather C52 | EVP, CFO &COO | Sell | 66,142 | $1.02 | $67,464.84 | -4.2% | -1.2% | +302.0% | |
| Jan 5, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 3,902 | $1.13 | $4,408.14 | - | 0.0% | -29.5% | |
| Jan 5, 2024 | STAA Staar Surgical Co | Broadwood Partners, L.P.60 | 10% Owner | Buy | 226,553 | $28.61 | $6,481,556.91 | +0.3% | +59.9% | -13.8% | |
| Jan 4, 2024 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 15,000 | $58.40 | $876,001.50 | -21.0% | +17.1% | +55.9% | |
| Jan 4, 2024 | COO Cooper Companies, Inc. | Petersmeyer Gary S59 | Director | Sell | 150 | $336.03 | $50,404.20 | -6.1% | +8.2% | +0.3% | |
| Jan 3, 2024 | INCY Incyte Corp | Stein Steven H55 | EVP &Chief Medical Officer | Sell | 7,365 | $65.51 | $482,481.15 | -7.5% | -14.8% | +6.1% | |
| Jan 3, 2024 | PEN Penumbra Inc | Grewal Harpreet60 | Director | Sell | 170 | $240.82 | $40,939.40 | -1.9% | -8.7% | +3.6% | |
| Jan 3, 2024 | ARAY Accuray Inc | Pervaiz Ali63 | SVP Chief Financial Officer | Sell | 2,116 | $2.74 | $5,800.17 | -0.5% | -10.0% | -27.8% | |
| Jan 3, 2024 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 11,931 | $57.82 | $689,862.35 | -17.4% | +17.1% | +55.2% | |
| Jan 3, 2024 | ARAY Accuray Inc | Corradetti Gina | VP, CAO And Controller | Sell | 14,129 | $2.74 | $38,729.00 | -6.7% | -10.0% | -27.8% | |
| Jan 3, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 5,522 | $1.09 | $6,018.82 | - | +4.5% | -33.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.